Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
Wai Chun Bio-Technology Ltd. ( (HK:0660) ) has shared an update.
Wai Chun Bio-Technology Ltd. held an Extraordinary General Meeting (EGM) on June 30, 2025, where all proposed resolutions were passed by poll. A key resolution involved a significant capital reduction, reducing the par value of each issued ordinary share from HK$0.25 to HK$0.01, effectively decreasing the company’s issued share capital from HK$44,619,113 to HK$1,784,764. This move is expected to impact the company’s financial structure and market positioning.
More about Wai Chun Bio-Technology Ltd.
Wai Chun Bio-Technology Ltd. is a company incorporated in the Cayman Islands, operating within the biotechnology sector. The company is listed on the Hong Kong Stock Exchange under the stock code 660.
Average Trading Volume: 197,101
Technical Sentiment Signal: Buy
Current Market Cap: HK$23.38M
For an in-depth examination of 0660 stock, go to TipRanks’ Overview page.